Records containing: Ovarian Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2012-10-10Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin
-
CLINICAL_TRIALS study record update · 2012-10-05ChemoFx® PRO - A Post-Market Data Collection Study Utilizing Physician Reported Outcomes
-
CLINICAL_TRIALS study record update · 2012-10-05A Non-Interventional Prospective Study of the Correlation of the Precision Therapeutics, Inc. Chemoresponse Assay With Progression-Free Survival in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer.
-
CLINICAL_TRIALS study record update · 2012-10-04Depression and IL-6 in Epithelial Ovarian Cancer: Genetic Diathesis and Psychological Stress
-
CLINICAL_TRIALS study record update · 2012-10-04A Study to Assess HER2-Specific T Cell Responses in Patients Receiving Trastuzumab for Solid Tumor Treatment
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-10-03Multicenter, Single-arm, Phase II Study of the Trifunctional Antibody Catumaxomab (Anti-EpCAM x Anti-CD3) Administered Intra- and Postoperatively in Patients With Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2012-09-26A Phase I/II Study of Intensive-Dose Etoposide, Topotecan and Carboplatin (ETC) Followed by Autologous Stem Cell Rescue in Chemosensitive Ovarian Cancer Patients With Either Minimal Residual Disease or at First Relapse
-
CLINICAL_TRIALS study record update · 2012-09-24A Randomized Phase III Study for the Treatment of Recurrent Epithelial Ovarian Cancer: Chemotherapy Alone Versus Chemotherapy Followed by Secondary Cytoreductive Surgery in Patients With a Treatment-Free Interval of More Than 12 Months
-
CLINICAL_TRIALS study record update · 2012-09-24Phase II Study on ET-743 in Advanced Soft Tissue Sarcomas of the Adult
-
CLINICAL_TRIALS study record update · 2012-09-24Open Label Phase II Study on RFS 2000 (9-Nitro-camptothecin, 9-NC) Administered as a "5 Days On-2 Days Off" Oral Treatment in Advanced Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2012-09-24Dose Finding and Phase II Study of STI 571 in Advanced Soft Tissue Sarcoma
-
CLINICAL_TRIALS study record update · 2012-09-21Amifostine (Ethyol) as a Protectant in Metastatic Ovarian and Non-Small Cell Lung Cancer in Paclitaxel/Carboplatin-Treated Patients: A Comparative Trial
-
CLINICAL_TRIALS study record update · 2012-09-18A Phase II Study of Hypofractionated Highly Conformal Radiation With Helical Tomotherapy for Extra-Cranial Oligo
-
CLINICAL_TRIALS study record update · 2012-09-06A Phase I, Open-label, Dose-escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Intravenously Administered ATI-1123, a Liposomal Docetaxel Formulation, on an Every 3 Week Schedule, in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2012-08-27An International Field Study of the Reliability and Validity of a Disease-Specific Questionnaire Module (the QLQ-OV28) in Assessing the Quality of Life of Patients With Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2012-08-24Phase II Evaluation Of Neoadjuvant Chemotherapy, Interval Debulking Followed By Intraperitoneal Chemotherapy In Women With Stage III And IV Epithelial Ovarian Cancer, Fallopian Tube Cancer Or Primary Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2012-08-23A Pilot Phase II Study Evaluating the Combination of Oxaliplatin and Docetaxel With Bevacizumab as First Line Therapy in Patients With FIGO Stage IB-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Carcinoma
-
CLINICAL_TRIALS study record update · 2012-08-23ClinicalTrials.gov study NCT00516841
-
CLINICAL_TRIALS study record update · 2012-08-21Phase II Study of Single Agent Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer With No Prior PARP Exposure or Prior PARP Inhibitor Exposure
-
CLINICAL_TRIALS study record update · 2012-08-13A Phase II Trial of Weekly, Low-Dose Docetaxel (Taxotere) in Patients With Platinum-Resistant Epithelial Ovarian or Primary Peritoneal Serous Cancer
-
CLINICAL_TRIALS study record update · 2012-08-09A Randomized Study of Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing
-
CLINICAL_TRIALS study record update · 2012-08-02A Phase I Study Evaluating the Safety and Tolerability of PS-341(Bortezomib)and Carboplatin in Patients With Platinum- and Taxane-Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer
-
CLINICAL_TRIALS study record update · 2012-08-02A Phase I/II Study to Evaluate the Optimum Dose of Pegylated-Interferon (PEG INTRON) in Patients With Platinum Resistant Ovarian, Peritoneal or Fallopian Tube Cancer
-
CLINICAL_TRIALS study record update · 2012-08-01Questionnaire for Ovarian Cancer Patients Regarding Acceptance and Willingness to Undergo Genetic Testing
-
CLINICAL_TRIALS study record update · 2012-07-31An International Phase III Randomised Trial of Dose Fractionated Chemotherapy Compared to Standard Three Weekly Chemotherapy, Following Immediate Primary Surgery or as Part of Delayed Primary Surgery, for Women With Newly Diagnosed Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer